Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Expanded breadth of virus neutralization after immunization with a multiclade envelope hiv vaccine candidate

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Chakrabarti, Bimal
  • Ling, X.
  • Yang, Z. Y.
  • Montefiori, D. C.
  • Panet, A.
  • Kong, W. P.
  • Welcher, B.
  • Louder, M. K.
  • Mascola, J. R.
  • Nabel, G. J.

publication date

  • May 2005

journal

  • Vaccine  Journal

abstract

  • Although the V3 loop of the human immunodeficiency virus type 1 (HIV-1) envelope (Env) effectively elicits potent neutralizing antibody responses, the specificity of the antibody response is often restricted to T cell line adapted (TCLA) strains and a small subset of primary isolates, limiting its utility for an AIDS vaccine. In this study, we have compared Env immunogens with substituted V3 regions to combinations of strains from different clades and evaluated their ability to expand the breadth of the neutralizing antibody response. When the V3 region from HIV BaL was substituted for HIV HXB2, an effective neutralizing antibody response against several clade B primary isolates was elicited, but it remained restricted to neutralization of most clade B isolates. In an attempt to expand this response further, a linear epitope recognized by the broadly neutralizing 2F5 antibody was inserted into V3. A V3 2F5 epitope was identified that bound to 2F5 and elicited a potent 2F5 antibody response as an immunogen, but the antisera neutralized only a lab-adapted strain and not primary isolates. In contrast, combinations of Envs from clades A, B, and C, elicited neutralizing antibodies to a more diverse group of primary HIV-1 isolates. These studies suggest that combinations of Env immunogens, despite the limited reactivity of the V3 from each component, can be used to expand the breadth of the neutralizing antibody response.

subject areas

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Infections
  • HIV-1
  • Humans
  • Immunization
  • Neutralization Tests
  • Peptide Fragments
  • Viral Envelope Proteins
scroll to property group menus

Research

keywords

  • AIDS vaccines
  • HIV-1 neutralizing antibodies
  • multiclade vaccine
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0264-410X

Digital Object Identifier (DOI)

  • 10.1016/j.vaccine.2005.01.099

PubMed ID

  • 15837367
scroll to property group menus

Additional Document Info

start page

  • 3434

end page

  • 3445

volume

  • 23

issue

  • 26

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support